Faron vs Tolerx, Inc.

Faron logo

Faron

A CLEVER Approach to Fight Cancer

61 employees · est. 2007 · Turku, Finland

VS
Tolerx, Inc. logo

Tolerx, Inc.

9 employees · est. 2000 · Cambridge, United States

Tolerx, Inc. is the older company (2007 vs 2000); Faron is the larger of the two.

Side-by-Side Comparison

Faron Tolerx, Inc.
Founded
2007 2000 older
Headquarters
Turku, Finland Cambridge, United States
Employees
61 larger 9
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Post-IPO Debt Venture round
Total Funding
$61.34M $145.50M
Funding Rounds
9 5
Services
Development of innovative cancer therapies, Conducting clinical trials, Research in immunotherapy and myeloid cell-targeting, Drug candidate investigation and development Not tracked yet
Target Customers
Cancer patients, Healthcare professionals, Clinical researchers, Investors in biopharmaceuticals Not tracked yet
Taxonomy
Clinical Stage BiopharmaceuticalBexmarilimabPrecision ImmunotherapyMacrophage Checkpoint ImmunotherapyHematological MalignanciesAnti-Clever-1 Antibody +9 Cancer TreatmentDiabetes TreatmentAutoimmune DiseaseImmunotherapyT Cell ImmunotherapyDrug Development +8
Website
faron.com tolerx.com
Faron logo

About Faron

Faron, a clinical stage biopharmaceutical company with the slogan "A CLEVER Approach to Fight Cancer," is focused on developing novel immunotherapies to address unmet medical needs. Headquartered in Turku, Finland, and Boston, Massachusetts, its flagship program is bexmarilimab, an investigational p...

Tolerx, Inc. logo

About Tolerx, Inc.

Tolerx, Inc. is a trailblazer in immunology, with a remarkable array of pioneering drug candidates designed to combat not only type 1 diabetes, but also a range of autoimmune disorders and cancer by restoring balance to immune responses. The company's lineup features otelixizumab, its primary candid...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Faron and Tolerx, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Faron or Tolerx, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Faron was founded in 2007, based in Turku, Finland, with 61 employees. Faron, a clinical stage biopharmaceutical company with the slogan "A CLEVER Approach to Fight Cancer," is focused on developing novel immunotherapies to address unmet medical needs. Headquartered in T. Tolerx, Inc. was founded in 2000, based in Cambridge, United States, with 9 employees. Tolerx, Inc. is a trailblazer in immunology, with a remarkable array of pioneering drug candidates designed to combat not only type 1 diabetes, but also a range of autoimmune disorders and cancer by r.
Faron has raised $61.34M and Tolerx, Inc. $145.50M. Latest stage: Faron Post-IPO Debt, Tolerx, Inc. Venture round.
Both work in Biotechnology and list drug development among their focus areas.

Compare Faron with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Faron on 15 Jun 2026, and Tolerx, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes